Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| TScan Therapeutics, Inc.(TCRX) | 630,000 | 630,000 | 0 | $1.92M | $869.4K | 42.07% | -$1.05M |
| Barinthus BiotherapeuticsADS | 642,204 | 642,204 | 0 | $775.8K | $624.7K | 30.22% | -$151.1K |
| Werewolf Therapeutics, Inc.(HOWL) | 589,102 | 589,102 | 0 | $871.9K | $572.7K | 27.71% | -$299.1K |